Abstract
Deregulated expression of Ras and myc oncogenes confers neoplastic transformation in non-tumorigenic mammary epithelial cells. Down-regulation of perturbed biomarkers prior to tumorigenesis may provide a means of effective chemoprevention. In vitro experiments were designed to i) identify specific molecular, endocrine and cellular biomarkers as quantitative end points for preneoplastic transformation, and ii) utilize these end points to evaluate chemopreventive efficacy of selected naturally-occurring and synthetic tumor inhibitors. Stable Ras and myc transfectants exhibited persistent expression of oncogene specific mRNA transcripts, altered estradiol biotransformation and enhanced anchorage-independent growth in vitro prior to tumorigenesis in vivo. Treatment of the transfectants with omega-3-fatty acid, indole-3-carbinol and tamoxifen individually suppressed the perturbed molecular, endocrine and cellular biomarkers in vitro. Thus, suppressed oncogen expression and altered estrogen metabolism may be important determinants for antiproliferative mechanisms in mammary tumor inhibition, providing useful end points for chemopreventive intervention of preneoplasia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Welsch, C.W. and Aylsworth, C.F. J. Natl. Cancer Inst. 70:215–221, 1983.
Tinsley, I.J., Schmitz, J.A. and Pierce, D.A. Cancer Res. 41:1460–1465, 1981.
Telang, N.T., Bockman, R.S., Modak, M.J. and Osborne, M.P. In: Carcinogenesis and Dietary Fat. (Ed. S. Abraham), Kluwer Academic Publishers, Boston, 1989, pp. 427–451.
Jordan, V.C., Lababidi, M.K. and Langan-Fahey, S. J. Natl. Cancer Inst. 83:492–496, 1991.
Bradlow, H.L., Michnovicz, J.J., Telang, N.T. and Osborne, M.P. Carcinogenesis 12:1571–1574, 1991.
Medina, D. J. Natl. Cancer Inst. 53:213–221, 1974.
Cardiff, R.D. Adv. Cancer Res. 42:167–190, 1984.
Banerjee, M.R. In: In Vitro Models for Cancer Research. (M.M. Weber and L.I. Sekeley, Eds.), CRC Press, Boca Raton, FL., 1986, pp. 69–114.
Telang, N.T., Bradlow, H.L. and Osborne, M.P. J. Cell Biochem. 16G:161–169, 1992.
Telang, N.T., Kurihara, H., Wong, G.Y., Bradlow, H.L. and Osborne, M.P. Anticancer Res. 11:1021–1028, 1991
Telang, N.T., Osborne, M.P., Swetelitsch, L.A. and Narayanan, R. Cell Regulation 1:863–872, 1990.
Telang, N.T., Narayanan, R., Bradlow, H.L. and Osborne, M.P. Breast Cancer Res. Treat. 18:155–163, 1991.
Garg, A., Suto, A., Osborne, M.P. Gupta, R.C. and Telang, N.T. Int. J. Oncol. 3:185–189, 1993.
Telang, N.T., Basu, A., Kurihara, H., Osborne, M.P. and Modak, M.J. Anticancer Res. 8:971–976, 1989.
Jurkowski, J.J. and Cave, W.T. J. Natl. Cancer Inst. 74:1145–1150, 1985.
Gabor, H. and Abraham, S. J. Natl. Cancer Inst. 76:1223–1229, 1986.
Karmali, R. Prev. Med. 16:483–502, 1987.
Tsai, M.-H., Yu, C.-L. and Stacey, D.W. Science 250:982–985, 1990.
Tsai, M.-H., Yu, T.-H., Wei, F.-S. and Stacey, D.W. Science 243:522–526, 1988.
Suto, A., Bradlow, H.L., Kubota, T., Kitajima, M., Wong, G.Y.C., Osborne, M.P. and Telang, N.T. Steroids 58:215–219, 1993.
Suto, A., Bradlow, H.L., Wong, G.Y.C., Osborne M.P. and Telang, N.T. Steroids 57:262–268, 1992.
Suto, A., Bradlow, H.L., Wong, G.Y.C., Osborne, M.P. and Telang, N.T. Breast Cancer Res. Treat. 24. (in press), 1993.
Schneider, J., Huh, M.M., Bradlow, H.L. and Fishman, J. J. Biol. Chem. 259:4840–4845, 1984.
Telang, N.T., Suto, A., Wong, G.Y.C., Osborne, M.P. and Bradlow, H.L. J. Natl. Cancer Inst. 84:634–638, 1992.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Telang, N.T., Inoue, S., Leon Bradlow, H., Osborne, M.P. (1997). Negative Growth Regulation of Oncogene-Transformed Mammary Epithelial Cells by Tumor Inhibitors. In: Honn, K.V., Nigam, S., Marnett, L.J. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 2. Advances in Experimental Medicine and Biology, vol 400. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5325-0_55
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5325-0_55
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7430-5
Online ISBN: 978-1-4615-5325-0
eBook Packages: Springer Book Archive